CEPHALON INC
FDA Approved Drugs

CEPHALON INC

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued RX Unclassified
  • Total Records 31
  • Latest Approval Date Oct 13, 2017
  • Data Source FDA
  • First Approval Date Oct 04, 1993
All
31
View
Unclassified
1
View
Discontinued
23
View
RX
7
View
Company Overview

Company

CEPHALON INC

Country

U.S.A

Website

Visit Website

Email

Social Profiles

Company Snapshot

CEPHALON INC

4745 Wiley Post Way Salt Lake City, UT 84116

U.S.A

www.tevapharm.com/ View on Map
FDA Approved Drug Records ( 31 records )
1998
04 Nov
Discontinued Application: 20747

Drug Name

ACTIQ

Product Number

1

Dosage Form

-

Strength

EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

20747 / 1

Active Ingredient

FENTANYL CITRATE

Application Number

20747

Product Number

1

Dosage Form

-

Strength

EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

Regulatory Status

Discontinued

1998
04 Nov
Discontinued Application: 20747

Drug Name

ACTIQ

Product Number

2

Dosage Form

-

Strength

EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

20747 / 2

Active Ingredient

FENTANYL CITRATE

Application Number

20747

Product Number

2

Dosage Form

-

Strength

EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

Regulatory Status

Discontinued

1998
04 Nov
Discontinued Application: 20747

Drug Name

ACTIQ

Product Number

3

Dosage Form

-

Strength

EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

20747 / 3

Active Ingredient

FENTANYL CITRATE

Application Number

20747

Product Number

3

Dosage Form

-

Strength

EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

Regulatory Status

Discontinued

1998
04 Nov
Discontinued Application: 20747

Drug Name

ACTIQ

Product Number

4

Dosage Form

-

Strength

EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

20747 / 4

Active Ingredient

FENTANYL CITRATE

Application Number

20747

Product Number

4

Dosage Form

-

Strength

EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

Regulatory Status

Discontinued

1998
04 Nov
Discontinued Application: 20747

Drug Name

ACTIQ

Product Number

5

Dosage Form

-

Strength

EQ 1.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

20747 / 5

Active Ingredient

FENTANYL CITRATE

Application Number

20747

Product Number

5

Dosage Form

-

Strength

EQ 1.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

Regulatory Status

Discontinued

1998
04 Nov
Discontinued Application: 20747

Drug Name

ACTIQ

Product Number

6

Dosage Form

-

Strength

EQ 1.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

20747 / 6

Active Ingredient

FENTANYL CITRATE

Application Number

20747

Product Number

6

Dosage Form

-

Strength

EQ 1.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1998-11-04

Regulatory Status

Discontinued

1993
04 Oct
Discontinued Application: 20195

Drug Name

FENTANYL

Product Number

1

Dosage Form

-

Strength

EQ 0.2MG BASE

Approval Date

1993-10-04

20195 / 1

Active Ingredient

FENTANYL CITRATE

Application Number

20195

Product Number

1

Dosage Form

-

Strength

EQ 0.2MG BASE

Approval Date

1993-10-04

Regulatory Status

Discontinued

1993
04 Oct
Discontinued Application: 20195

Drug Name

FENTANYL

Product Number

2

Dosage Form

-

Strength

EQ 0.3MG BASE

Approval Date

1993-10-04

20195 / 2

Active Ingredient

FENTANYL CITRATE

Application Number

20195

Product Number

2

Dosage Form

-

Strength

EQ 0.3MG BASE

Approval Date

1993-10-04

Regulatory Status

Discontinued

1993
04 Oct
Discontinued Application: 20195

Drug Name

FENTANYL

Product Number

3

Dosage Form

-

Strength

EQ 0.4MG BASE

Approval Date

1993-10-04

20195 / 3

Active Ingredient

FENTANYL CITRATE

Application Number

20195

Product Number

3

Dosage Form

-

Strength

EQ 0.4MG BASE

Approval Date

1993-10-04

Regulatory Status

Discontinued

1995
30 Oct
Discontinued Application: 20195

Drug Name

FENTANYL

Product Number

7

Dosage Form

-

Strength

EQ 0.1MG BASE

Approval Date

1995-10-30

20195 / 7

Active Ingredient

FENTANYL CITRATE

Application Number

20195

Product Number

7

Dosage Form

-

Strength

EQ 0.1MG BASE

Approval Date

1995-10-30

Regulatory Status

Discontinued

2006
25 Sep
Discontinued Application: 21947

Drug Name

FENTORA

Product Number

1

Dosage Form

-

Strength

EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

21947 / 1

Active Ingredient

FENTANYL CITRATE

Application Number

21947

Product Number

1

Dosage Form

-

Strength

EQ 0.1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

Regulatory Status

Discontinued

2006
25 Sep
Discontinued Application: 21947

Drug Name

FENTORA

Product Number

2

Dosage Form

-

Strength

EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

21947 / 2

Active Ingredient

FENTANYL CITRATE

Application Number

21947

Product Number

2

Dosage Form

-

Strength

EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

Regulatory Status

Discontinued

2006
25 Sep
Discontinued Application: 21947

Drug Name

FENTORA

Product Number

3

Dosage Form

-

Strength

EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

21947 / 3

Active Ingredient

FENTANYL CITRATE

Application Number

21947

Product Number

3

Dosage Form

-

Strength

EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

Regulatory Status

Discontinued

2006
25 Sep
Discontinued Application: 21947

Drug Name

FENTORA

Product Number

4

Dosage Form

-

Strength

EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

21947 / 4

Active Ingredient

FENTANYL CITRATE

Application Number

21947

Product Number

4

Dosage Form

-

Strength

EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

Regulatory Status

Discontinued

2006
25 Sep
Discontinued Application: 21947

Drug Name

FENTORA

Product Number

5

Dosage Form

-

Strength

EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

21947 / 5

Active Ingredient

FENTANYL CITRATE

Application Number

21947

Product Number

5

Dosage Form

-

Strength

EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2006-09-25

Regulatory Status

Discontinued

2007
02 Mar
Discontinued Application: 21947

Drug Name

FENTORA

Product Number

6

Dosage Form

-

Strength

EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2007-03-02

21947 / 6

Active Ingredient

FENTANYL CITRATE

Application Number

21947

Product Number

6

Dosage Form

-

Strength

EQ 0.3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2007-03-02

Regulatory Status

Discontinued

1997
30 Sep
RX Application: 20646

Drug Name

GABITRIL

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

1997-09-30

20646 / 1

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

1997-09-30

Regulatory Status

RX

1997
30 Sep
RX Application: 20646

Drug Name

GABITRIL

Product Number

2

Dosage Form

-

Strength

12MG

Approval Date

1997-09-30

20646 / 2

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

2

Dosage Form

-

Strength

12MG

Approval Date

1997-09-30

Regulatory Status

RX

1997
30 Sep
RX Application: 20646

Drug Name

GABITRIL

Product Number

3

Dosage Form

-

Strength

16MG

Approval Date

1997-09-30

20646 / 3

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

3

Dosage Form

-

Strength

16MG

Approval Date

1997-09-30

Regulatory Status

RX

1997
30 Sep
Discontinued Application: 20646

Drug Name

GABITRIL

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

1997-09-30

20646 / 4

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

4

Dosage Form

-

Strength

20MG

Approval Date

1997-09-30

Regulatory Status

Discontinued

1999
16 Apr
RX Application: 20646

Drug Name

GABITRIL

Product Number

5

Dosage Form

-

Strength

2MG

Approval Date

1999-04-16

20646 / 5

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

5

Dosage Form

-

Strength

2MG

Approval Date

1999-04-16

Regulatory Status

RX

2005
29 Nov
Discontinued Application: 20646

Drug Name

GABITRIL

Product Number

6

Dosage Form

-

Strength

6MG

Approval Date

2005-11-29

20646 / 6

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

6

Dosage Form

-

Strength

6MG

Approval Date

2005-11-29

Regulatory Status

Discontinued

2005
29 Nov
Discontinued Application: 20646

Drug Name

GABITRIL

Product Number

7

Dosage Form

-

Strength

8MG

Approval Date

2005-11-29

20646 / 7

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

7

Dosage Form

-

Strength

8MG

Approval Date

2005-11-29

Regulatory Status

Discontinued

2005
29 Nov
Discontinued Application: 20646

Drug Name

GABITRIL

Product Number

8

Dosage Form

-

Strength

10MG

Approval Date

2005-11-29

20646 / 8

Active Ingredient

TIAGABINE HYDROCHLORIDE

Application Number

20646

Product Number

8

Dosage Form

-

Strength

10MG

Approval Date

2005-11-29

Regulatory Status

Discontinued

2008
20 Mar
RX Application: 22249

Drug Name

TREANDA

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2008-03-20

22249 / 1

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Application Number

22249

Product Number

1

Dosage Form

-

Strength

100MG/VIAL

Approval Date

2008-03-20

Regulatory Status

RX

2009
01 May
RX Application: 22249

Drug Name

TREANDA

Product Number

2

Dosage Form

-

Strength

25MG/VIAL

Approval Date

2009-05-01

22249 / 2

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Application Number

22249

Product Number

2

Dosage Form

-

Strength

25MG/VIAL

Approval Date

2009-05-01

Regulatory Status

RX

2013
13 Sep
Discontinued Application: 22249

Drug Name

TREANDA

Product Number

3

Dosage Form

-

Strength

45MG/0.5ML (90MG/ML)

Approval Date

2013-09-13

22249 / 3

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Application Number

22249

Product Number

3

Dosage Form

-

Strength

45MG/0.5ML (90MG/ML)

Approval Date

2013-09-13

Regulatory Status

Discontinued

2013
13 Sep
Discontinued Application: 22249

Drug Name

TREANDA

Product Number

4

Dosage Form

-

Strength

180MG/2ML (90MG/ML)

Approval Date

2013-09-13

22249 / 4

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Application Number

22249

Product Number

4

Dosage Form

-

Strength

180MG/2ML (90MG/ML)

Approval Date

2013-09-13

Regulatory Status

Discontinued

-
Unclassified Application: 22303

Drug Name

TREANDA

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

22303 / 1

Active Ingredient

BENDAMUSTINE HYDROCHLORIDE

Application Number

22303

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

2000
25 Sep
Discontinued Application: 21248

Drug Name

TRISENOX

Product Number

1

Dosage Form

-

Strength

1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2000-09-25

21248 / 1

Active Ingredient

ARSENIC TRIOXIDE

Application Number

21248

Product Number

1

Dosage Form

-

Strength

1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2000-09-25

Regulatory Status

Discontinued

2017
13 Oct
RX Application: 21248

Drug Name

TRISENOX

Product Number

2

Dosage Form

-

Strength

2MG/ML

Approval Date

2017-10-13

21248 / 2

Active Ingredient

ARSENIC TRIOXIDE

Application Number

21248

Product Number

2

Dosage Form

-

Strength

2MG/ML

Approval Date

2017-10-13

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    31 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
31 total
  • Discontinued
  • RX
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACTIQ

Application Number

20747

Product Number

1

Active Ingredient

FENTANYL CITRATE

Dosage Form

-

Strength

EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit